MEDIUM confidence: 100% data completeness, but the composite (49) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Net insider -$1.1M over 180 days (0 open-market buys, 2 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $17.9B— | $16.3B-9.1% | $15.4B-5.1% | $14.7B-4.5% | $14.3B-3.0% |
| EPS (dil.) | $-1.05— | $1.71n/m | $0.05-97.4% | $-0.53-1270.0% | $-3.00n/m |
| Free Cash Flow | $2.5B— | $2.5B+0.1% | $2.3B-7.4% | $2.0B-15.0% | $1.9B-2.0% |
| Gross Margin | 31.2% | 40.0%+8.8pp | 41.7%+1.8pp | 38.2%-3.6pp | 35.1%-3.1pp |
| Operating Margin | -0.2% | 9.9%+10.1pp | 5.0%-5.0pp | 0.1%-4.9pp | -18.6%-18.7pp |
| Net Margin | -7.1% | 12.8%+19.9pp | 0.4%-12.4pp | -4.3%-4.7pp | -24.6%-20.3pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Buy-rated share 55% → 50% over ~3 months (-5pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Aug 2026 | $0.60 | $0.69 | +14.8% |
| May 2026 | $0.50 | $0.59 | +17.5% |
| Feb 2026 | $0.53 | $0.57 | +7.1% |
| Nov 2025 | $0.62 | $0.67 | +7.9% |
| Aug 2025 | $0.56 | $0.62 | +11.5% |
| May 2025 | $0.49 | $0.50 | +1.6% |
| Feb 2025 | $0.61 | $0.54 | -11.5% |
| Nov 2024 | $0.68 | $0.75 | +10.8% |
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth below the analyst consensus of 1.5%/yr (revenue basis).
Base free cash flow $2.1B (avg FY2023–FY2025; latest year $1.9B) · equity value $19.0B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 49 for Viatris Inc. indicates a neutral outlook, with the stock's short-term and long-term scores relatively aligned. The stock scores high on risk and exhibits strong momentum, with a 12-month return of 61.1%, but is dragged down by poor growth metrics, including a significant decline in EPS growth. The stock trades at a P/E of -45.3 and EV/EBITDA of 12.0, with a relatively high FCF yield of 9.9%, suggesting a mixed valuation picture.